Karuna Therapeutics Sees Breakthrough In Schizophrenia Drug
Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
A study by the Netherlands Institute of Neuroscience found that the human brain appears to understand what it sees differently depending on what it expects.
The Centers for Disease Control and Prevention published an official health advisory warning healthcare providers to keep a lookout for children with possible lead poisoning from certain applesauce products.